Workflow
Corbus Pharmaceuticals(CRBP) - 2023 Q1 - Quarterly Report

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | --- | --- | |----------------------------------------------------------------------------------------------|---------------------------------------------| | For the transition period | from________ to_________. | | Commission File 001-37348 | Number: | | Corbus Pharmaceuticals Holdings, Inc. (Exact name of registrant as specified | in its charter) | | Delaware | 46-4348039 | | (State or other jurisdiction of incorpor ...